{"id":"W2045769757","doi":"10.5539/ijsp.v4n1p33","title":"Dose Finding Method in Joint Modeling of Efficacy and Safety Endpoints in Phase II Studies","year":2014,"lang":"en","type":"article","venue":"International Journal of Statistics and Probability","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health","keywords":"Clinical trial; Clinical endpoint; Medicine; Drug development; Selection (genetic algorithm); Phase (matter); Confirmatory factor analysis; Efficacy; Estimation; Surrogate endpoint; Computer science; Joint (building); Phases of clinical research; Medical physics; Drug; Reliability engineering; Pharmacology; Structural equation modeling; Internal medicine; Machine learning; Engineering; Chemistry","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02230613,0.001294417,0.002451085,0.001705416,0.0005110825,0.001384777,0.002654713,0.001981315,0.003015781],"category_scores_gemma":[0.03981079,0.0009314349,0.002143252,0.001691416,0.001364058,0.001962555,0.002305868,0.00306398,0.0006224102],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001279508,"about_ca_system_score_gemma":0.002666973,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002315426,"about_ca_topic_score_gemma":0.001669326,"domain_scores_codex":[0.9895374,0.008073979,0.0003293061,0.0009825864,0.0008610138,0.0002156937],"domain_scores_gemma":[0.9728624,0.02321651,0.001248119,0.001410482,0.0009504542,0.0003120989],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.0008340662,0.0002051263,0.00461596,0.0005978091,0.0006678985,0.000343666,0.0003799598,0.6266789,0.00284878,0.1168198,0.003723381,0.2422846],"study_design_scores_gemma":[0.0001269645,0.0001927385,0.000403836,0.00004740792,0.0001257083,0.000126212,0.00001928918,0.9419063,0.001068358,0.05294031,0.003013486,0.00002942935],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"genre_codex":"methods","genre_gemma":"methods","genre_scores_codex":[0.001678071,0.0001953547,0.9975453,0.00009505117,0.00001655455,0.0001007231,0.00003565442,0.0001116415,0.0002215974],"genre_scores_gemma":[0.1207646,0.0005760866,0.8748962,0.0003155574,0.0001334692,0.001128215,0.0002571722,0.0001762763,0.001752302],"genre_candidate":"methods","genre_consensus":"methods","teacher_disagreement_score":0.02230613,"threshold_uncertainty_score":0.1179675,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4833261219747756,"score_gpt":0.57762695267772,"score_spread":0.09430083070294437,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}